JPWO2022154045A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022154045A5
JPWO2022154045A5 JP2022575626A JP2022575626A JPWO2022154045A5 JP WO2022154045 A5 JPWO2022154045 A5 JP WO2022154045A5 JP 2022575626 A JP2022575626 A JP 2022575626A JP 2022575626 A JP2022575626 A JP 2022575626A JP WO2022154045 A5 JPWO2022154045 A5 JP WO2022154045A5
Authority
JP
Japan
Prior art keywords
cancer
sclec2
cancers
c2pac
dvt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022575626A
Other languages
English (en)
Japanese (ja)
Other versions
JP7808059B2 (ja
JPWO2022154045A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/000891 external-priority patent/WO2022154045A1/ja
Publication of JPWO2022154045A1 publication Critical patent/JPWO2022154045A1/ja
Publication of JPWO2022154045A5 publication Critical patent/JPWO2022154045A5/ja
Application granted granted Critical
Publication of JP7808059B2 publication Critical patent/JP7808059B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022575626A 2021-01-13 2022-01-13 可溶型clec2を用いた癌患者における血栓症リスクの予測方法 Active JP7808059B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021003671 2021-01-13
JP2021003671 2021-01-13
PCT/JP2022/000891 WO2022154045A1 (ja) 2021-01-13 2022-01-13 可溶型clec2を用いた癌患者における血栓症リスクの予測方法

Publications (3)

Publication Number Publication Date
JPWO2022154045A1 JPWO2022154045A1 (https=) 2022-07-21
JPWO2022154045A5 true JPWO2022154045A5 (https=) 2024-10-29
JP7808059B2 JP7808059B2 (ja) 2026-01-28

Family

ID=82448474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022575626A Active JP7808059B2 (ja) 2021-01-13 2022-01-13 可溶型clec2を用いた癌患者における血栓症リスクの予測方法

Country Status (6)

Country Link
US (1) US20240288435A1 (https=)
EP (1) EP4279606A4 (https=)
JP (1) JP7808059B2 (https=)
KR (1) KR20230131222A (https=)
CN (1) CN116761895A (https=)
WO (1) WO2022154045A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090297508A1 (en) * 2005-04-25 2009-12-03 University Of Yamanashi Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
CA2610910A1 (en) 2005-06-09 2006-12-21 Paul H. Mcpherson Methods and compositions for the diagnosis of venous thromboembolic disease
CN104093741B (zh) * 2011-03-22 2016-12-07 公益财团法人癌研究会 小鼠抗Aggrus单克隆抗体
JP6078845B2 (ja) * 2012-09-28 2017-02-15 株式会社Lsiメディエンス 可溶型clec−2に基づく血小板活性化測定方法
CA2993624A1 (en) * 2015-08-07 2017-02-16 Thomas Helledays Stiftelse For Medicinsk Forskning Method for diagnosisng cancer or cancer-associated thrombosis by measuring levels of h3cit in plasma
FR3048001B1 (fr) 2016-02-18 2018-02-09 Diagnostica Stago Methode de dosage des d-dimeres specifiques de la maladie thromboembolique veineuse
EP4113524A4 (en) * 2020-02-28 2024-03-06 LSI Medience Corporation METHOD FOR MEASURING PLATELE ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELE COUNT

Similar Documents

Publication Publication Date Title
Morson Precancerous lesions of the colon and rectum: Classification and controversial issues
Jang et al. Laparoscopic excision of a choledochal cyst in 82 consecutive patients
JP2020511414A5 (https=)
JP2020513745A5 (https=)
Kim et al. Kinematic analysis of swallowing in the patients with esophagectomy for esophageal cancer
Michel-Flutot et al. Effects of C2 hemisection on respiratory and cardiovascular functions in rats
JPWO2022154045A5 (https=)
Mikołajczyk-Solińska et al. Life-threatening anaemia in patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
Katta et al. Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy
Hocker et al. Orthostatic hypotension following resection of a dorsal medullary hemangioblastoma
RU2685796C1 (ru) Способ лечения больных местно-распространенными злокачественными опухолями полости рта и языка
Rozhkovsky et al. Educational and methodical manual for practical classes in pharmacotherapy with the basics of pharmacokinetics for the students of the IV course of the pharmaceutical faculty of full-time education
Pomara et al. Autonomic nervous system instability, tetanic necrosis of the heart and myocardial TNFα expression in a tetanus fatal case
Pichkate et al. Case report on carcinoma gallbladder with severe abdominal pain.
RU2728932C2 (ru) Терапевтическое средство для лечения рака желчевыводящих путей
Baishya et al. Recurrent dermatofibrosarcoma protuberans of lower anterior chest wall in a young male with early fibrosarcomatous change: Dermatofibrosarcoma protuberans
Maistrenko et al. Cytoreductive Surgery in Elderly and Senile Patients with Disseminated forms of Colorectal Cancer
Xu et al. 1510TiP A phase II study of a patented oral fecal microbiota capsule for reprogramming immunity in advanced hepatocellular carcinoma (HCC) resistant to immune checkpoint inhibitors (ICIs)
Chang Re: Association between Treatment of Superficial Bladder Cancer and 10-Year Mortality in Older Adults with Multiple Chronic Conditions
Mulder et al. Cost-effectiveness of the three EMA-approved adjuvant systemic therapies in patients with high-risk melanoma: a model-based economic evaluation
Buchholz et al. U. Schroeder, M. Lauten, G. Stichtenoth, MPE Gebhard
Kaur et al. Hailey–Hailey disease: a case treated with topical tacrolimus
Tsara et al. Sleep-disordered breathing and hypoventilation with a large right-side pleura-based mass
Sakuma et al. Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination
Al-Tubaikh Obesity, Gastric Banding, and Liposuction